Back
AbbVie Vs. Merck & Industry Stock Comparison
Buy
70
ABBV
AbbVie
Last Price:
$202.13
Seasonality Move:
3.69%
Sell
27
MRK
Merck &
Last Price:
$89.50
Seasonality Move:
2.49%
Sell
27
Merck & (MRK)
is a Sell
Is Merck & a Buy, Sell or Hold?
-
MRK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ABBV Stock Price Chart
ABBV Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 5.78 | Buy |
Relative Strength Index (14 RSI): | 77.27 | Buy |
Chaikin Money Flow: | 248436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (174.59 - 195.65) | Buy |
Bollinger Bands (100): | (173.32 - 194.44) | Buy |
MRK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -3.21 | Sell |
Relative Strength Index (14 RSI): | 45.2 | Sell |
Chaikin Money Flow: | 15242806 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (86.2 - 97.94) | Sell |
Bollinger Bands (100): | (93.39 - 107.19) | Sell |
ABBV Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 195.96 | Buy |
20-day SMA: | 188.51 | Buy |
50-day SMA: | 180.71 | Buy |
200-day SMA: | 180.85 | Buy |
8-day EMA: | 196.58 | Buy |
20-day EMA: | 190.38 | Buy |
50-day EMA: | 184.74 | Buy |
200-day EMA: | 179.85 | Buy |
MRK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 85.71 | Buy |
20-day SMA: | 90.73 | Sell |
50-day SMA: | 96.01 | Sell |
200-day SMA: | 111.71 | Sell |
8-day EMA: | 87.05 | Buy |
20-day EMA: | 89.81 | Sell |
50-day EMA: | 94.7 | Sell |
200-day EMA: | 106.38 | Sell |
AbbVie Earnings Growth & ABBV Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.23 per share, an increase this year of $2.10 per share, and an increase next year of $1.57 per share.
Merck & Earnings Growth & MRK Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.89 per share, a decrease next quarter of $0.11 per share, an increase this year of $1.38 per share, and an increase next year of $0.92 per share.
AbbVie Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Merck & Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |